Rowan O Brothers1, Nir Atlas2, Kyle R Cowdrick1, Erin M Buckley1,3,4. 1. Emory University and Georgia Institute of Technology, Wallace H. Coulter Department of Biomedical Engineering, Atlanta, Georgia, United States. 2. Emory University and Children's Healthcare of Atlanta, Division of Critical Care Medicine, Department of Pediatrics, Atlanta, Georgia, United States. 3. Emory University School of Medicine, Department of Pediatrics, Atlanta, Georgia, United States. 4. Children's Healthcare of Atlanta, Children's Research Scholar, Atlanta, Georgia, United States.
Abstract
Significance: Cerebrovascular reactivity (CVR), defined as the ability of the cerebral vasculature to dilate or constrict in response to a vasoactive stimulus, is an important indicator of the brain's vascular health. However, mechanisms of cerebrovascular dysregulation are poorly understood, and no effective treatment strategies for impaired CVR exist. Preclinical murine models provide an excellent platform for interrogating mechanisms underlying CVR dysregulation and determining novel therapeutics that restore impaired CVR. However, quantification of CVR in mice is challenging. Aim: We present means of assessing CVR in awake mice using intraperitoneal injection of acetazolamide (ACZ) combined with continuous monitoring of cerebral blood flow. Approach: Measurements of cerebral blood flow were made with a minimally invasive diffuse correlation spectroscopy sensor that was secured to an optical window glued to the intact skull. Two source-detector separations (3 and 4.5 mm) per hemisphere were used to probe different depths. CVR was quantified as the relative increase in blood flow due to ACZ. CVR was assessed once daily for 5 days in 5 mice. Results: We found that CVR and the response half-time were remarkably similar across hemispheres and across 3- versus 4.5-mm separations, suggesting a homogenous, whole brain response to ACZ. Mean(std) intra- and intermouse coefficients of variations were 15(9)% and 19(10)%, respectively, for global CVR and 24(15)% and 27(11)%, respectively, for global response half-time. Conclusion: In sum, we report a repeatable method of measuring CVR in free-behaving mice which can be used to screen for impairments with disease and to track changes in CVR with therapeutic interventions.
Significance: Cerebrovascular reactivity (CVR), defined as the ability of the cerebral vasculature to dilate or constrict in response to a vasoactive stimulus, is an important indicator of the brain's vascular health. However, mechanisms of cerebrovascular dysregulation are poorly understood, and no effective treatment strategies for impaired CVR exist. Preclinical murine models provide an excellent platform for interrogating mechanisms underlying CVR dysregulation and determining novel therapeutics that restore impaired CVR. However, quantification of CVR in mice is challenging. Aim: We present means of assessing CVR in awake mice using intraperitoneal injection of acetazolamide (ACZ) combined with continuous monitoring of cerebral blood flow. Approach: Measurements of cerebral blood flow were made with a minimally invasive diffuse correlation spectroscopy sensor that was secured to an optical window glued to the intact skull. Two source-detector separations (3 and 4.5 mm) per hemisphere were used to probe different depths. CVR was quantified as the relative increase in blood flow due to ACZ. CVR was assessed once daily for 5 days in 5 mice. Results: We found that CVR and the response half-time were remarkably similar across hemispheres and across 3- versus 4.5-mm separations, suggesting a homogenous, whole brain response to ACZ. Mean(std) intra- and intermouse coefficients of variations were 15(9)% and 19(10)%, respectively, for global CVR and 24(15)% and 27(11)%, respectively, for global response half-time. Conclusion: In sum, we report a repeatable method of measuring CVR in free-behaving mice which can be used to screen for impairments with disease and to track changes in CVR with therapeutic interventions.
Authors: Detian Wang; Ashwin B Parthasarathy; Wesley B Baker; Kimberly Gannon; Venki Kavuri; Tiffany Ko; Steven Schenkel; Zhe Li; Zeren Li; Michael T Mullen; John A Detre; Arjun G Yodh Journal: Biomed Opt Express Date: 2016-02-03 Impact factor: 3.732
Authors: François Mathieu; Abdelhakim Khellaf; Jerry C Ku; Joseph Donnelly; Eric P Thelin; Frederick A Zeiler Journal: J Neurosurg Anesthesiol Date: 2020-10 Impact factor: 3.956
Authors: Jill B De Vis; Esben T Petersen; Alex Bhogal; Nolan S Hartkamp; Catharina J M Klijn; L J Kappelle; J Hendrikse Journal: J Cereb Blood Flow Metab Date: 2015-02-25 Impact factor: 6.200
Authors: Laibaik Park; Ping Zhou; Rose Pitstick; Carmen Capone; Josef Anrather; Erin H Norris; Linda Younkin; Steven Younkin; George Carlson; Bruce S McEwen; Costantino Iadecola Journal: Proc Natl Acad Sci U S A Date: 2008-01-17 Impact factor: 11.205